Publications in collaboration with researchers from Hospital Clinico Universitario de Valencia (37)

2024

  1. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study

    Multiple Sclerosis and Related Disorders, Vol. 90

  2. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

    Frontiers in Neurology , Vol. 15

2023

  1. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

  2. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

2021

  1. 1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress

    Revista de Neurologia

  2. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240

  3. Impact of the COVID-19 pandemic on the training of Spanish neurology residents

    Neurology Perspectives, Vol. 1, Núm. 2, pp. 124-130

  4. Opicapone for the treatment of Parkinson’s disease: real-life data in Spain

    Revista de Neurologia, Vol. 73, pp. S1-S14

  5. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project

    Brain Sciences, Vol. 11, Núm. 8

  6. Spanish expert consensus on the use of safinamide in Parkinson's disease

    Neurologia, Vol. 36, Núm. 9, pp. 666-672

  7. The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish

    Headache, Vol. 61, Núm. 9, pp. 1403-1410

2020

  1. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

  2. Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey

    Neurologia, Vol. 35, Núm. 4, pp. 252-257

2019

  1. Clinical Predictors of Hyperperfusion Syndrome Following Carotid Stenting: Results From a National Prospective Multicenter Study

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 9, pp. 873-882

  2. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417

  3. Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain

    Odontology, Vol. 107, Núm. 4, pp. 530-535

2018

  1. Comorbidity between idiopathic overactive bladder and chronic migraine

    Cephalalgia, Vol. 38, Núm. 3, pp. 581-584

2016

  1. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy

    Epilepsy and Behavior, Vol. 65, pp. 25-32

2014

  1. Errors in recognition and management are still frequent in patients with cluster headache

    European Neurology, Vol. 72, pp. 209-212